Aethlon Medical
AEMD
11 hedge funds and large institutions have $975K invested in Aethlon Medical in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, reducing their positions, and 3 closing their positions.
43% more capital invested
Capital invested by funds: $684K → $975K (+$292K)
0% more funds holding
Funds holding: 11 → 11 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$231K |
| 2 |
CFN
Cordasco Financial Network
Naples,
Florida
|
+$207K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
+$24.4K |
| 4 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
+$12.2K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$12.2K |
Top Sellers
| 1 |
VF
Virtu Financial
New York
|
-$57K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$39K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$19K |
AEMD Hedge Fund Activity: Q4 2017 in Review
11 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q4 2017, worth a combined $975K — up 43% from $684K a quarter earlier.
Fund positioning in AEMD was balanced in Q4 2017: 3 funds opened new positions, 3 closed out, 3 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, adding an estimated $231K. The largest seller was Virtu Financial, exiting entirely with an estimated $57K sold.
- 11 institutional investors held Aethlon Medical (AEMD) as of Q4 2017, unchanged from Q3 2017.
- Funds reported $975K of Aethlon Medical stock for Q4 2017, up 43% quarter-over-quarter.
- 3 funds opened new Aethlon Medical positions in Q4 2017 and 3 closed out, a net change of 0 holders.
- The largest Aethlon Medical buyer in Q4 2017 was Vanguard Group, an estimated $231K added.
- The largest Aethlon Medical seller in Q4 2017 was Virtu Financial, an estimated $57K sold.
Based on aggregated 13F filings for Q4 2017.